DAPSONE AS A SECOND GLUCOCORTICOID-SPARING AGENT IN ADDITION TO AZATHIOPRINE IN TREATMENT OF PEMPHIGUS VULGARIS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

SHAMS DAVACHI SH.; BALIGHI K.; YAZDANIAN SH.; NABAEI B.

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Dermatology Year:2007 | Volume:10 | Issue:2 (40) Page(s): 111-118

Download Full-Text

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

View:

1,363

Download:

Cites:

Information Journal Paper

Title

DAPSONE AS A SECOND GLUCOCORTICOID-SPARING AGENT IN ADDITION TO AZATHIOPRINE IN TREATMENT OF PEMPHIGUS VULGARIS

Author(s)

SHAMS DAVACHI SH. | BALIGHI K. | YAZDANIAN SH. | NABAEI B. | Issue Writer Certificate

Keywords

PEMPHIGUS VULGARISQ3

SYSTEMIC STEROIDQ3

DAPSONEQ4

COMPLICATIONSQ3

RELAPSEQ3

Abstract

Background and aim: PEMPHIGUS VULGARIS is an autoimmune vesiculobullous disorder. Prior to the advent of glucocorticoid therapy, it was often fatal. Now its mortality and morbidity is due to high dose glucocorticoid COMPLICATIONS rather than the disease itself. This study was aimed to determine the effect of DAPSONE as a second adjuvant in the treatment of PEMPHIGUS VULGARIS.Materials and methods: In this quasi-experimental open prospective study, 22 patients with moderate to severe PEMPHIGUS VULGARIS were treated with prednisolone, azathioprine and DAPSONE. They were observed for 12-18 months.Results: Patients consisted of 10 females and 12 males with mean age of 41.71 years. The mean duration to reach to the maintenance dose of prednisolone (7.5 mg daily) was 13 months. No major RELAPSE was observed but minor RELAPSEs were seen in 6 patients with mean prednisolone dose of 13.8 mg daily. Hemolysis was detected in only one patientand 4 patients had a little drop in hemoglobin level. We observed no other severe DAPSONE induced adverse reaction.Conclusion: These findings suggest that DAPSONE can be used as a second adjuvant for more rapid tapering of steroid dosage without significant flare of the disease.

Cites

No record.

References

No record.

Cite

APA: Copy

SHAMS DAVACHI, SH., BALIGHI, K., YAZDANIAN, SH., & NABAEI, B.. (2007). DAPSONE AS A SECOND GLUCOCORTICOID-SPARING AGENT IN ADDITION TO AZATHIOPRINE IN TREATMENT OF PEMPHIGUS VULGARIS. IRANIAN JOURNAL OF DERMATOLOGY, 10(2 (40)), 111-118. SID. https://sid.ir/paper/57964/en

Vancouver: Copy

SHAMS DAVACHI SH., BALIGHI K., YAZDANIAN SH., NABAEI B.. DAPSONE AS A SECOND GLUCOCORTICOID-SPARING AGENT IN ADDITION TO AZATHIOPRINE IN TREATMENT OF PEMPHIGUS VULGARIS. IRANIAN JOURNAL OF DERMATOLOGY[Internet]. 2007;10(2 (40)):111-118. Available from: https://sid.ir/paper/57964/en

IEEE: Copy

SH. SHAMS DAVACHI, K. BALIGHI, SH. YAZDANIAN, and B. NABAEI, “DAPSONE AS A SECOND GLUCOCORTICOID-SPARING AGENT IN ADDITION TO AZATHIOPRINE IN TREATMENT OF PEMPHIGUS VULGARIS,” IRANIAN JOURNAL OF DERMATOLOGY, vol. 10, no. 2 (40), pp. 111–118, 2007, [Online]. Available: https://sid.ir/paper/57964/en

Related Journal Papers